Alexion Pharma Nordics Holding AB
ActiveKey figures
Key figures
2025Summary: Alexion Pharma Nordics Holding AB
What kind of company is it?
Alexion Pharma Nordics Holding AB (org. no. 559097-5495) is a limited company (AB). The company was registered in 2017 and has existed for 9 years. Registered seat: Stockholm. Industry according to Statistics Sweden: activities of non-financial holding companies (SNI 64212).
How is the company doing financially?
The company had no net sales in financial year 2025. Financial year 2025 ended with a loss of 299 522 342 kr. The company was profitable in 2 of the 3 reported financial years. At the end of financial year 2025, total assets were 2 272 301 951 kr and equity 2 200 503 951 kr (equity ratio 96,8 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 3 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Summary of annual reports2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Sales revenue | 0 | 0 | 0 |
| Profit for the reporting year | 181 086 417 | 267 239 487 | −299 522 342 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 2 324 899 130 | 2 612 528 424 | 2 272 301 951 |
| Total liabilities | 92 112 324 | 112 502 131 | 71 798 000 |
| Total equity | 2 232 786 806 | 2 500 026 293 | 2 200 503 951 |
| Employees | — | — | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.